Department of Stroke Center, Seirei Hamamatsu General Hospital.
Department of Neurosurgery, Hamamatsu University School of Medicine.
Neurol Med Chir (Tokyo). 2021 Jul 15;61(7):397-403. doi: 10.2176/nmc.oa.2020-0412. Epub 2021 May 14.
Mechanical thrombectomy (MT) is a proven treatment for acute ischemic stroke (AIS). However, the efficacy of this treatment is uncertain for very elderly patients. This study aimed to investigate the safety and effectiveness of MT in 90 years or older patients compared with younger patients. We retrospectively reviewed AIS patients treated with MT between October 2018 and June 2020 in our institution. Patients were divided into two groups: aged ≥90 and <90 years. We compared the following factors: functional outcome at discharge, in-hospital death, successful recanalization, and complications. Multivariate logistic regression analysis for the good functional outcome was performed. In consideration of pre-stroke basic activities of very elderly patients, we defined the good functional outcome as modified Rankin Scale (mRS) 0-3. In all, 66 patients were included, and 19 patients (28%) were ≥90 years old. Pre-stoke mRS was higher in ≥90-year-old patients (p = 0.01). In ≥90-year-old patients, we achieved successful recanalization in 17 patients (90%), and only one patient experienced hemorrhagic complication related with the procedure. The good functional outcome (mRS: 0-3) at discharge were six patients (32%) in ≥90 years old versus 19 patients (40%) in <90 years old (p = 0.6). Three patients died in hospital in each group (16% versus 6%) (p = 0.3). Only the stroke severity was negatively related with the good functional outcome in a multivariate analysis. In conclusion, for ≥90-year-old patients compared with younger patients, MT is an equally feasible therapy. Patients should not be excluded from MT based on age alone.
机械取栓 (MT) 是治疗急性缺血性脑卒中 (AIS) 的有效方法。然而,对于非常高龄的患者,这种治疗的疗效尚不确定。本研究旨在探讨 90 岁及以上患者与年轻患者相比,MT 的安全性和有效性。我们回顾性分析了 2018 年 10 月至 2020 年 6 月在我院接受 MT 治疗的 AIS 患者。患者分为两组:年龄≥90 岁和<90 岁。我们比较了以下因素:出院时的功能结局、住院期间死亡、再通成功和并发症。对良好功能结局进行了多变量逻辑回归分析。考虑到非常高龄患者的基础活动能力,我们将良好的功能结局定义为改良 Rankin 量表(mRS)0-3。共纳入 66 例患者,其中 19 例(28%)≥90 岁。≥90 岁患者的术前 mRS 更高(p=0.01)。在≥90 岁的患者中,我们有 17 例(90%)实现了再通,只有 1 例患者发生了与手术相关的出血并发症。出院时的良好功能结局(mRS:0-3)在≥90 岁的患者中为 6 例(32%),而在<90 岁的患者中为 19 例(40%)(p=0.6)。两组各有 3 例患者在住院期间死亡(16%比 6%)(p=0.3)。多变量分析仅显示卒中严重程度与良好功能结局呈负相关。总之,与年轻患者相比,对于≥90 岁的患者,MT 是一种同样可行的治疗方法。不应仅根据年龄将患者排除在 MT 治疗之外。